Opdivo® (Nivolumab) Intravenous Infusion Approved for Supplemental Indication of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck with Disease Progression on or after Platinum-based Therapy in Taiwan 2017.08.16 Opdivo® (Nivolum Thursday August 17th, 2017By Tokio X'press JPN, Pharmaceutical
QIA Direct Equity Ownership in Credit Suisse Falls Below 5% QIA Direct Equity Ownership in Thursday August 17th, 2017By Tokio X'press Fund, Soverign
Cerberus Sells Out Seibu Shareholdings 20170816 Cerberus Sells O Thursday August 17th, 2017By Tokio X'press Holdings, JPN
HondaJet Obtains Brazilian Type Certification. Aug 15, 2017 – GREENSBORO, N.C. HondaJet Obtains Wednesday August 16th, 2017By Tokio X'press Aviation, JPN HondaJet
Snack, Crackle, Drop! Temasek Exits Snapcha Snack, Crackle, Wednesday August 16th, 2017By Tokio X'press SIN, Fund